Abneesh Roy from Nuvama Institutional Equities discusses Britannia’s positive growth outlook despite local competition and tech disruption, while also reflecting on challenges faced by Titan in the jewelry segment and eyewear business.
Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi’s lab will be releasing their March quarter